Cancer Research UK logo.
SearchDonate
  • Search

A trial of pemetrexed or etoposide with cisplatin and radiotherapy for locally advanced non small cell lung cancer (PROCLAIM)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC)

Status:

Results

Phase:

Phase 3

Details

This trial compared pemetrexed or etoposide alongside cisplatin and radiotherapy for non small cell lung cancer.

It was open to people with non small cell lung cancer that had grown into surrounding tissues () and it could not be removed with an operation.

Recruitment start: 20 January 2008

Recruitment end: 31 August 2012

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Mayukh Das

Supported by

Eli Lilly and Company Limited

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Last reviewed: 27 October 2016

CRUK internal database number: 972

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.